DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice
Authors
Keywords
SARS CoV 2, Antibodies, Immune response, DNA vaccination, Enzyme-linked immunoassays, Viral vaccines, Vaccine development, Vaccines
Journal
PLoS One
Volume 16, Issue 3, Pages e0248007
Publisher
Public Library of Science (PLoS)
Online
2021-03-23
DOI
10.1371/journal.pone.0248007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
- (2020) Shuai Xia et al. CELL RESEARCH
- Developing Covid-19 Vaccines at Pandemic Speed
- (2020) Nicole Lurie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- DNA vaccine protection against SARS-CoV-2 in rhesus macaques
- (2020) Jingyou Yu et al. SCIENCE
- Immunogenicity of a DNA vaccine candidate for COVID-19
- (2020) Trevor R. F. Smith et al. Nature Communications
- The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
- (2020) Yosra A. Helmy et al. Journal of Clinical Medicine
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
- (2020) Christopher O. Barnes et al. CELL
- Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
- (2020) Bao-zhong Zhang et al. CELL RESEARCH
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- Next-generation vaccine platforms for COVID-19
- (2020) Debby van Riel et al. NATURE MATERIALS
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- COVID-19 Vaccine: A comprehensive status report
- (2020) Simran Preet Kaur et al. VIRUS RESEARCH
- A candidate multi-epitope vaccine against SARS-CoV-2
- (2020) Tamalika Kar et al. Scientific Reports
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
- (2020) Yang Li et al. Cellular & Molecular Immunology
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma
- (2020) Lluc Farrera-Soler et al. PLoS One
- Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
- (2020) Subodh Kumar Samrat et al. VIRUS RESEARCH
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
- (2018) Fan Luo et al. VIROLOGICA SINICA
- Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
- (2016) Anurodh Shankar Agrawal et al. Human Vaccines & Immunotherapeutics
- A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
- (2014) L. Du et al. JOURNAL OF VIROLOGY
- Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines
- (2014) Eakachai Prompetchara et al. PLoS One
- Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
- (2014) Ming Yip et al. Virology Journal
- Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit Vaccine Candidates
- (2013) Jie Li et al. VIRAL IMMUNOLOGY
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
- (2011) M. Bolles et al. JOURNAL OF VIROLOGY
- T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice
- (2010) J. Zhao et al. JOURNAL OF VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started